| Pharmaceutical active ingredients: |
| Fluorescein SodiumOxybuprocaine Hydrochloride |
| Available forms, composition and doses of Thilorbin: |
| N / A |
| Thilorbin medical category: |
| Human:DiagnosticsLocal anesthetics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01JA51 - Fluorescein, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Alcon |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Flurate | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Bausch and Lomb |
| Flurekain | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Croma Pharma |
| Fluress | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Allergan; Abigo Medical; Advanced Medical Optics; Akorn; Pilkington Barnes Hind |
| Flurox | Fluorescein Sodium; Oxybuprocaine Hydrochloride | CYNACON / OCuSOFT |
| Oftan Flurekain | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Santen Pharmaceutical |
| Dioflur-P | Fluorescein Sodium; Proparacaine Hydrochloride | Dioptic Laboratories |
| Fluoracaine | Fluorescein Sodium; Proparacaine Hydrochloride | Akorn; Dioptic Laboratories |
| Fluorocaine | Fluorescein Sodium; Proparacaine Hydrochloride | Medical Ophthalmics |
| Minims Proxymetacaine and Fluorescein | Fluorescein Sodium; Proparacaine Hydrochloride | Chauvin Pharmaceuticals |
| Caducid | Fluoresone | Istituto Farmacoterapico Italiano |